OpenAlex
PricingAboutJobs
Log inGet started
Author

Hong Yu

Institution: Tianjin Medical University General Hospital
Observed institution: Tianjin Medical University General Hospital
ORCID: 0000-0001-7025-7328
Observed ORCID: 0000-0001-7025-7328
OpenAlex ID: A5018668124
Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial
2022 · Jia Song, Hui Liu, et al. · Blood · 7
Ixazomib, Pomalidomide and Dexamethasone (IxaPD) Pan-Oral Regimen in the Treatment of Refractory and Relapsed Multiple Myeloma
2024 · Miao Chen, Hong Yu, et al. · Blood · 1
PDF
A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
2026 · Runfeng Zhang, Hong Yu, et al. · British Journal of Haematology
PDF
Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China
2022 · Zhe Zhuang, Ying Tian, et al. · Blood
Works count: 4
Citation count: 8
H-index: 1
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security